Surgery Partners (SGRY) to Release Quarterly Earnings on Tuesday

Surgery Partners (NASDAQ:SGRY) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.21 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm had revenue of $762.10 million during the quarter, compared to analysts’ expectations of $735.94 million. During the same period in the prior year, the company posted $0.25 earnings per share. Surgery Partners’s revenue for the quarter was up 14.2% on a year-over-year basis. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Stock Up 1.6 %

SGRY stock opened at $29.22 on Tuesday. The business’s 50 day moving average is $31.20 and its 200-day moving average is $28.26. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96. Surgery Partners has a 1-year low of $22.25 and a 1-year high of $36.92.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Benchmark restated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. Citigroup decreased their target price on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Macquarie reiterated an “outperform” rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday. Finally, UBS Group initiated coverage on shares of Surgery Partners in a research report on Monday, October 14th. They set a “buy” rating and a $38.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $40.13.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.